| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 30.074 | 26.935 | 62.422 | 54.806 | 3.131 | 7.014 | 13.089 | 7.134 | 16.607 | 8.393 |
| Total Income - EUR | 30.074 | 26.935 | 69.324 | 55.601 | 3.771 | 7.282 | 13.568 | 7.218 | 16.623 | 8.394 |
| Total Expenses - EUR | 16.486 | 18.776 | 20.694 | 30.908 | 28.925 | 11.994 | 8.983 | 15.431 | 6.195 | 20.901 |
| Gross Profit/Loss - EUR | 13.589 | 8.159 | 48.630 | 24.693 | -25.154 | -4.712 | 4.585 | -8.214 | 10.428 | -12.507 |
| Net Profit/Loss - EUR | 12.686 | 7.620 | 47.937 | 24.138 | -25.189 | -4.872 | 4.266 | -8.376 | 10.325 | -12.591 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Ethys Scientific Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 8.781 | 4.491 | 16.707 | 10.791 | 5.160 | 449 | 269 | 99 | 42 | 0 |
| Current Assets | 19.333 | 6.326 | 37.307 | 49.287 | 18.331 | 14.068 | 13.069 | 2.853 | 13.548 | 5.200 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 4.074 | 0 | 32.708 | 16.656 | 887 | 237 | 595 | 257 | 401 | 902 |
| Cash | 15.259 | 6.326 | 4.599 | 32.631 | 17.444 | 13.831 | 12.474 | 2.596 | 13.147 | 4.298 |
| Shareholders Funds | 22.519 | 7.674 | 47.989 | 53.151 | 22.497 | 13.455 | 11.805 | 1.972 | 12.268 | 4.445 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 5.594 | 3.144 | 6.025 | 6.928 | 994 | 803 | 1.280 | 980 | 1.322 | 853 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 258 | 253 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8559 - 8559" | |||||||||
| CAEN Financial Year |
8559
|
|||||||||
Comments - Ethys Scientific Srl